Instrument Inactif

Gouvernance Alexion Pharmaceuticals, Inc.

ALXN

US0153511094

Produits pharmaceutiques

Comité Exécutif: Alexion Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Marc Dunoyer

73 ans

Chief Executive Officer

Gianluca Pirozzi

49 ans

General Counsel

01/10/2019

Sean Christie

53 ans

Chief Administrative Officer	01/08/2021
Director of Finance/CFO	01/08/2021

Patryk Mikucki

51 ans

Chief Tech/Sci/R&D Officer

Seng Cheng

Chief Tech/Sci/R&D Officer

01/07/2023

Ruth Diazaraque

Chief Tech/Sci/R&D Officer

01/06/2023

Nicola Heffron

54 ans

Sales & Marketing

01/04/2023

Christophe Hotermans

Chief Tech/Sci/R&D Officer

01/07/2021

Sarah Marshall

Human Resources Officer

01/12/2022

Doyle Shane

Chief Operating Officer

Composition du Conseil d'Administration: Alexion Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Ruud Dobber

Compensation Committee	18/06/2021
Governance Committee	18/06/2021
Nominating Committee	18/06/2021

Dernières Nominations: Alexion Pharmaceuticals, Inc.

14/07/21	L'approbation du Royaume-Uni ouvre la voie à la conclusion de l'opération AstraZeneca-Alexion la semaine prochaine.	RE
04/06/21	AstraZeneca confie un nouveau rôle au directeur financier après la transaction avec Alexion	RE

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Alexion Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Jack Mollen

Director/Board Member	17/04/2014	14/07/2021
Independent Dir/Board Member	17/04/2014	14/07/2021

Andreas Rummelt

Director/Board Member	23/02/2010	14/07/2021
Independent Dir/Board Member	21/11/2011	14/07/2021

David Brennan

Director/Board Member	16/07/2014	10/05/2017
Chief Executive Officer	12/12/2016	27/03/2017
Chairman	10/05/2017	14/07/2021
Independent Dir/Board Member	27/03/2017	14/07/2021

Christopher Coughlin

Director/Board Member	16/07/2014	14/07/2021
Independent Dir/Board Member	-	14/07/2021

Julie O'Neill

Chief Operating Officer

01/01/2015

01/09/2018

Michael V. Greco

General Counsel	18/09/2014	01/06/2018
Corporate Secretary	01/02/2007	01/06/2018

Alvin S. Parven

Director/Board Member	01/05/1999	08/05/2018
Independent Dir/Board Member	01/05/1999	08/05/2018

M. Burns

Director/Board Member	16/07/2014	08/05/2018
Independent Dir/Board Member	-	08/05/2018

Elena Ridloff

Investor Relations Contact

01/04/2014

01/03/2018

John Moriarty

General Counsel

01/12/2012

01/02/2018

Heidi Wagner

General Counsel

16/02/2010

01/01/2018

Camille Bedrosian

Chief Tech/Sci/R&D Officer

13/07/2009

01/01/2018

Rockford Norby

Director/Board Member	01/09/1999	14/09/2017
Independent Dir/Board Member	01/09/1999	14/09/2017

Clare M. Carmichael

Human Resources Officer

07/09/2011

01/06/2017

Martin MacKay

Chief Tech/Sci/R&D Officer

07/05/2013

01/06/2017

Leonard Bell

Director/Board Member	01/01/1992	-
Chief Executive Officer	01/01/1992	01/04/2015
Chairman	01/01/1992	10/05/2017
Founder	01/01/1992	10/05/2017
Corporate Secretary	01/01/1992	13/05/2011
Treasurer	01/01/1992	01/04/2015

Edward Miller

Compliance Officer

17/09/2014

01/05/2017

Vikas Sinha

Director of Finance/CFO

01/09/2005

12/12/2016

David Hallal

Director/Board Member	17/09/2014	12/12/2016
Chief Executive Officer	01/04/2015	12/12/2016
Chief Operating Officer	16/09/2014	01/04/2015
Corporate Officer/Principal	01/06/2006	16/09/2014

Saqib Islam

Corporate Officer/Principal

01/02/2013

01/02/2016

Dominique Monnet

Sales & Marketing

01/05/2014

01/10/2015

William Keller

Director/Board Member	02/12/2009	06/05/2015
Independent Dir/Board Member	01/12/2009	06/05/2015

Jeremy Springhorn

Corporate Officer/Principal

01/01/2006

01/03/2015

Stephen Squinto

Chief Operating Officer	07/05/2012	01/01/2015
Chief Tech/Sci/R&D Officer	01/01/2007	07/05/2012
Founder	01/01/1992	01/01/2015

Max E. Link

Chairman	01/04/1992	05/10/2014
Independent Dir/Board Member	01/04/1992	05/10/2014

Joseph A. Madri

Director/Board Member	01/01/1992	05/05/2014
Founder	01/01/1992	05/05/2014
Independent Dir/Board Member	01/01/1992	05/05/2014
Corporate Officer/Principal	01/01/1992	07/06/2010

Larry L. Mathis

Director/Board Member	01/03/2004	05/05/2014
Independent Dir/Board Member	21/11/2011	05/05/2014

Francis Wright

Corporate Officer/Principal

01/12/2012

01/01/2014

Claude Nicaise

General Counsel

13/07/2009

01/01/2014

James Bilotta

Chief Tech/Sci/R&D Officer

16/02/2010

01/01/2014

Thomas Bock

Chief Tech/Sci/R&D Officer

01/01/2010

01/09/2013

Cheryl Nash

Corporate Officer/Principal

01/01/2009

Patrice Coissac

Corporate Officer/Principal

01/11/2005

08/02/2013

Thomas Dubin

General Counsel

01/01/2001

Abbie Celniker

Corporate Officer/Principal

01/01/2011

01/08/2011

Claus Weisemann

Compliance Officer

01/01/2011

Ruedi E. Waeger

Director/Board Member

01/03/2005

12/05/2010

Ann Margaret Veneman

Director/Board Member	03/06/2010	-
Independent Dir/Board Member	01/05/2010	-

Darren Cline

Sales & Marketing

01/10/2006

01/10/2009

Eric Grinstead

General Counsel

01/09/2006

01/07/2009

Arthur Edwards

Corporate Officer/Principal

01/01/2004

01/01/2009

David W. Keiser

Chief Operating Officer	01/01/1992	31/12/2008
Founder	01/01/1992	31/12/2008
President	01/01/1992	31/12/2008

Nancy C. Motola

General Counsel

01/01/1998

Paul W. Finnegan

Sales & Marketing

01/04/2001

01/09/2007

Glenn R. Melrose

Human Resources Officer

01/07/2007

Christopher F. Mojcik

Corporate Officer/Principal

01/07/1998

26/06/2007

Lars Robert Boesgaard

Corporate Officer/Principal

01/01/2004

01/01/2007

Carsten Boess

Director of Finance/CFO

01/01/2004

01/01/2005

M. Stacy Hooks

Chief Tech/Sci/R&D Officer

01/07/2006

Russell P. Rother

Chief Tech/Sci/R&D Officer

01/01/1999

Barry P. Luke

Corporate Officer/Principal

01/05/1993

Louis Matis

Chief Tech/Sci/R&D Officer

01/01/1993

Scott Rollins

Founder	01/01/1992	-
Corporate Officer/Principal	01/01/1992	-

David Falconer

Corporate Officer/Principal

22/09/2009

Victoria Hughes

Corporate Officer/Principal

Deborah Ramsdell

Chief Tech/Sci/R&D Officer

George Zavoico

Corporate Officer/Principal

James G. Stout

Corporate Officer/Principal

Karen L. Tubridy

Corporate Officer/Principal

Katherine Bowdish

Corporate Officer/Principal	-	-
President	-	-

Eric Frieden

Corporate Officer/Principal

Farzana Malik

Corporate Officer/Principal

Irving Adler

Public Communications Contact

Scott Phillips

Comptroller/Controller/Auditor

Ginger M. More

Director/Board Member	-	-
Corporate Officer/Principal	-	-

James A. Wilkins

Corporate Officer/Principal

Tim F. Howe

Director/Board Member

Jerry T. Jackson

Director/Board Member

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	11
Femme	3

Dont comité exécutif

Homme	8
Femme	2

Dont Administrateurs

Homme	1
Femme	0

Alexion Pharmaceuticals, Inc. est une société biopharmaceutique. La société se concentre sur la découverte, le développement et la commercialisation de médicaments. Les produits commercialisés par la société comprennent ULTOMIRIS, SOLIRIS (eculizumab), STRENSIQ (asfotase alfa), KANUMA (sebelipase alfa) et ANDEXXA (facteur Xa de coagulation - [recombinant] inactivé-zhzo). Son produit ULTOMIRIS est un inhibiteur C5 à action prolongée, qui agit en inhibant la protéine C5 dans la cascade du complément terminal. Son produit SOLIRIS est un anticorps monoclonal humanisé qui bloque l'activité terminale aux doses prescrites. Son produit Strensiq est un traitement enzymatique substitutif ciblé pour les patients atteints d'hypophosphatasie (HPP). Son produit Kanuma est une forme recombinante de l'enzyme lipase acide lysosomale (LAL) humaine. Son produit ANDEXXA est un agent d'inversion pour les patients traités par rivaroxaban ou apixaban.

Employés

3 837

Secteur

Produits pharmaceutiques

Plus d'informations sur la société